Enovis (NYSE:ENOV – Get Rating) and Surgalign (NASDAQ:SRGA – Get Rating) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations. Analyst Ratings This is a summary of current ratings and recommmendations for […]
Horizon Kinetics Asset Management LLC trimmed its holdings in shares of Enovis Co. (NYSE:ENOV – Get Rating) by 9.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 6,679 shares of the company’s stock after selling 666 shares during the quarter. Horizon Kinetics […]
Shares of Enovis Co. (NYSE:ENOV – Get Rating) have received an average rating of “Moderate Buy” from the ten brokerages that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 1 year price objective […]
Broadcrest Asset Management LLC grew its holdings in Enovis Co. (NYSE:ENOV – Get Rating) by 20.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 300,000 shares of the company’s stock after purchasing an additional 50,000 shares during the quarter. Enovis comprises 17.5% of Broadcrest […]
Redmond Asset Management LLC trimmed its stake in Enovis Co. (NYSE:ENOV – Get Rating) by 55.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,310 shares of the company’s stock after selling 6,734 shares during the period. Redmond Asset Management LLC’s holdings […]